Cargando…
Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase
Metformin (Met) has been widely used in hypoglycemic therapy, and it is also able to reduce the incidence of tumors and tumor-related mortality. The present study investigated whether Met could inhibit the proliferation of lung cancer cells and enhance the sensitivity of a cisplatin-resistant lung c...
Autores principales: | WANG, YAJUN, LIN, BIYUN, WU, JUN, ZHANG, HAITAO, WU, BIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114589/ https://www.ncbi.nlm.nih.gov/pubmed/25120704 http://dx.doi.org/10.3892/ol.2014.2270 |
Ejemplares similares
-
The case for inhibiting p38 mitogen-activated protein kinase in heart failure
por: Arabacilar, Pelin, et al.
Publicado: (2015) -
BIRB796, an Inhibitor of p38 Mitogen-Activated Protein
Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
por: Zhao, Linyao, et al.
Publicado: (2021) -
Activation of p38 Mitogen-Activated Protein Kinase in Gaucher’s Disease
por: Kitatani, Kazuyuki, et al.
Publicado: (2015) -
P38 Mitogen-activated Protein Kinase and Parkinson’s Disease
por: He, Jianying, et al.
Publicado: (2018) -
Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
por: Bassi, Rekha, et al.
Publicado: (2017)